Martin Kreller

Head of Department

Helmholtz-Zentrum Dresden-Rossendorf

Germany

Research Interests

Explore related searches

Professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Martin Kreller is the Head of Department at Helmholtz-Zentrum Dresden-Rossendorf, Germany. His research primarily focuses on the production of medical radionuclides, with recent articles highlighting advancements in PET radionuclides and cyclotron-based production techniques. His work significantly contributes to the field of radionuclide theranostics and targeted alpha therapy.

Articles (10)

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Collaborators (1)

Constantin Mamat

Lecturer

Technische Universität Dresden

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Martin Kreller

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Production of Medical Radionuclides in the Center for Radiopharmaceutical Tumor Research—A Status Report

Production of Medical Radionuclides in the Center for Radiopharmaceutical Tumor Research—A Status Report

Production of the PET radionuclide <SUP>61</SUP>Cu via the <SUP>62</SUP>Ni(p,2n)<SUP>61</SUP>Cu nuclear reaction

Cyclotron-Based Production of <SUP>67</SUP>Cu for Radionuclide Theranostics via the <SUP>70</SUP>Zn(p,α)<SUP>67</SUP>Cu Reaction

Cyclotron-Based Production of 67Cu for Radionuclide Theranostics via the 70Zn(p,α)67Cu Reaction

Efficient Production of the PET Radionuclide Lanthanum-133

Elektrophile Synthese von 6-L-[18F]FDOPA mit [18F]F2: ein Statusbericht über das Gastarget am Zyklotron TR-Flex

Efficient Production of the PET Radionuclide <sup>133</sup>La for Theranostic Purposes in Targeted Alpha Therapy Using the <sup>134</sup>Ba(p,2n)<sup>133</sup>La Reaction

Efficient Production of the PET Radionuclide La-133 for Theranostic Purposes in Targeted Alpha Therapy Using the Ba-134(p,2n)La-133 Reaction

Quality assessment of cyclotron-produced 67Cu

Collaborators (1)

Constantin Mamat

Make your next move.